Pharmaceutical & BioTech
Discover all our Regulatory Affairs services
Drug Development
Regulatory Affairs
Market Access
Pharmacovigilance
Quality & Compliance
Marketing Authorization Application (MAA)
A GUIDE THROUGH DIFFERENT PROCEDURES
There are several procedures available to register pharmaceutical drugs in the EU:
- Centralized procedure, mandatory for specific product categories (e.g. orphan drugs).
- Mutual Recognition Procedure (MRP) or the Decentralized Procedure (DCP).
- National procedure.
Before the preparation of an MAA, RPN assists in developing a strategy to coordinate the generation of the needed documents and related procedures. A gap analysis is frequently embedded in the early phase of the process to highlight any potential issues with the draft dossier or the intended submission strategy.
EXPERTISE IN INTERNATIONAL AND LOCAL PROCEDURES
RPN combines capabilities at both the international and local levels so as to establish smooth communications with EMA and/or National Competent Authorities during the assessment of the MAA procedure and to drive faster approvals.
SUPPORT AT EVERY STAGE
RPN provides support for its clients at every stage of the MAA: writing, review, and submission of all modules required, oversight of the procedure throughout the assessment phase until the authorization is complete.
